Swedencare AB specializes in pet healthcare and produces partly in its factories, markets, and sells premium products on the global market. The company has a wide range of brands and products within most therapy areas, which includes Animal Pharmaceuticals, nutravet, NutriScience, PetMD, Stratford, VetWELL as well as ProDen PlaqueOff for oral health to dogs and cats. The company's products are sold in approximately fifty markets.
2010
579
LTM Revenue $261M
LTM EBITDA $59.5M
$700M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Swedencare has a last 12-month revenue of $261M and a last 12-month EBITDA of $59.5M.
In the most recent fiscal year, Swedencare achieved revenue of $252M and an EBITDA of $54.5M.
Swedencare expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Swedencare valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $232M | $252M | XXX | XXX | XXX |
Gross Profit | $101M | $128M | XXX | XXX | XXX |
Gross Margin | 43% | 51% | XXX | XXX | XXX |
EBITDA | $48.1M | $54.5M | XXX | XXX | XXX |
EBITDA Margin | 21% | 22% | XXX | XXX | XXX |
Net Profit | $9.4M | $5.8M | XXX | XXX | XXX |
Net Margin | 4% | 2% | XXX | XXX | XXX |
Net Debt | $139M | $120M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Swedencare's stock price is SEK 36 (or $4).
Swedencare has current market cap of SEK 5.8B (or $572M), and EV of SEK 7.0B (or $700M).
See Swedencare trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$700M | $572M | XXX | XXX | XXX | XXX | $0.10 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Swedencare has market cap of $572M and EV of $700M.
Swedencare's trades at 2.7x LTM EV/Revenue multiple, and 11.8x LTM EBITDA.
Analysts estimate Swedencare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Swedencare and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $700M | XXX | XXX | XXX |
EV/Revenue | 2.8x | XXX | XXX | XXX |
EV/EBITDA | 12.8x | XXX | XXX | XXX |
P/E | 58.3x | XXX | XXX | XXX |
P/E/Growth | 0.8x | XXX | XXX | XXX |
EV/FCF | 24.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSwedencare's NTM/LTM revenue growth is 12%
Swedencare's revenue per employee for the last fiscal year averaged $0.4M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Swedencare's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Swedencare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Swedencare and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 9% | XXX | XXX | XXX | XXX |
EBITDA Margin | 22% | XXX | XXX | XXX | XXX |
EBITDA Growth | 13% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 34% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.4M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 48% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Swedencare acquired XXX companies to date.
Last acquisition by Swedencare was XXXXXXXX, XXXXX XXXXX XXXXXX . Swedencare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Swedencare founded? | Swedencare was founded in 2010. |
Where is Swedencare headquartered? | Swedencare is headquartered in Sweden. |
How many employees does Swedencare have? | As of today, Swedencare has 579 employees. |
Who is the CEO of Swedencare? | Swedencare's CEO is Mr. Hakan Lagerberg. |
Is Swedencare publicy listed? | Yes, Swedencare is a public company listed on STO. |
What is the stock symbol of Swedencare? | Swedencare trades under SECARE ticker. |
When did Swedencare go public? | Swedencare went public in 2016. |
Who are competitors of Swedencare? | Similar companies to Swedencare include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of Swedencare? | Swedencare's current market cap is $572M |
What is the current revenue of Swedencare? | Swedencare's last 12-month revenue is $261M. |
What is the current EBITDA of Swedencare? | Swedencare's last 12-month EBITDA is $59.5M. |
What is the current EV/Revenue multiple of Swedencare? | Current revenue multiple of Swedencare is 2.7x. |
What is the current EV/EBITDA multiple of Swedencare? | Current EBITDA multiple of Swedencare is 11.8x. |
What is the current revenue growth of Swedencare? | Swedencare revenue growth between 2023 and 2024 was 9%. |
Is Swedencare profitable? | Yes, Swedencare is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.